William W. Busse - Concepedia

Author

William W. Busse

Also Known As

Bleecker, Eugene R., Busse, William, Busse, William W, Deepa Rastogi, John Kelly, W BUSSE, W Busse, W W Busse, W. BUSSE, W. Busse

935

Publications

63.4K

Citations

127

H-Index

230

Concepts

All Affiliations

University of Wisconsin–Madison University of Colorado Denver University of Pittsburgh National Jewish Health Wake Forest University

About

William W. Busse is an author at University of Wisconsin–Madison specializing in medicine, asthma, and allergy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	5	5	539
2	Arts	2	2	60
3	Engineering	2	2	163
4	Language Studies	2	2	134
5	Humanities	1	1	47

William W. Busse

344

Publications

47K

Citations

112

H-Index

Page 1

	Year	Citations
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program Wendy C. Moore, Deborah A. Meyers, Sally E. Wenzel, American Journal of Respiratory and Critical Care Medicine	2009	2.1K
An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations Helen K. Reddel, D. Robin Taylor, Eric D. Bateman, American Journal of Respiratory and Critical Care Medicine	2009	1.9K
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma Mario Castro, Jonathan Corren, Ian Pavord, New England Journal of Medicine	2018	1.8K
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial J. Mark FitzGerald, Eugene R. Bleecker, Parameswaran Nair, The Lancet AsthmaRheumatologyPlacebo-controlled Phase 3ImmunologyClinical Trials	2016	1.3K
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma William W. Busse, Jonathan Corren, Bobby Q. Lanier, Journal of Allergy and Clinical Immunology AsthmaAllergyAllergy MedicineImmunologyPeanut Allergy	2001	1.3K
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program Wendy C. Moore, Eugene R. Bleecker, Douglas Curran‐Everett, Journal of Allergy and Clinical Immunology AsthmaEpidemiologyNational HeartInflammatory Lung DiseaseAllergy	2007	926
Exploring the Effects of Omalizumab in Allergic Asthma Nicola A. Hanania, Sally E. Wenzel, Karin Rosén, American Journal of Respiratory and Critical Care Medicine	2013	873
Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children William W. Busse, Wayne J. Morgan, Peter J. Gergen, New England Journal of Medicine	2011	863
A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma Patrick Flood-Page, Cheri A. Swenson, Isidore Faiferman, American Journal of Respiratory and Critical Care Medicine	2007	737
Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma Jean Bousquet, Eva Mantzouranis, Álvaro A. Cruz, Journal of Allergy and Clinical Immunology AsthmaAsthma SeverityAllergyUniform DefinitionAllergy Medicine	2010	727

Page 1